Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12094-015-1452-2 http://scihub22266oqcxt.onion/10.1007/s12094-015-1452-2 C4689764!4689764!26650487     free     free     free       Clin+Transl+Oncol 2015 ; 17 (ä): 1036-42 Nephropedia Template TP {{tp|p=26650487|t=2015. SEOM guidelines for cervical cancer |pdf=|usr=}}{{26650487}} gab.com Text SEOM guidelines for cervical cancer JO: Clin Transl Oncol http://www.kidney.de/pget.php?&tw=1&pmid=26650487 #FOAvip Cervical cancer (CC) is the second most common cancer worldwide, strongly linked to high-risk human papilloma virus infection. Although screening programs have led to a relevant reduction in the incidence and mortality due to CC in developed countries, it is still an important cause of mortality in undeveloped countries. Clinical stage is still the most relevant prognostic factor. In early stages, the primary treatment is surgery or radiotherapy, whereas concomitant chemo-radiotherapy is the conventional approach in locally advanced stages. In the setting of recurrent or metastatic CC, for the first time ever, the combination of chemotherapy plus bevacizumab prolongs the overall survival beyond 12 months. Therefore, this regimen is considered by most of the oncologist a new standard of care for metastatic/recurrent CC. Twit Text FOAVip SEOM guidelines for cervical cancer ????Clin Transl Oncol http://www.kidney.de/pget.php?&tw=1&pmid=26650487 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26650487 #FOAvip English Wikipedia <ref>{{Cite pmid|26650487}}</ref> SEOM guidelines for cervical cancer #MMPMID26650487 Oaknin A; Rubio MJ; Redondo A; De Juan A; Cueva Bañuelos JF; Gil-Martin M; Ortega E; Garcia-Arias A; Gonzalez-Martin A; Bover I Clin Transl Oncol 2015[]; 17 (ä): 1036-42 PMID26650487show ga Cervical cancer (CC) is the second most common cancer worldwide, strongly linked to high-risk human papilloma virus infection. Although screening programs have led to a relevant reduction in the incidence and mortality due to CC in developed countries, it is still an important cause of mortality in undeveloped countries. Clinical stage is still the most relevant prognostic factor. In early stages, the primary treatment is surgery or radiotherapy, whereas concomitant chemo-radiotherapy is the conventional approach in locally advanced stages. In the setting of recurrent or metastatic CC, for the first time ever, the combination of chemotherapy plus bevacizumab prolongs the overall survival beyond 12 months. Therefore, this regimen is considered by most of the oncologist a new standard of care for metastatic/recurrent CC. äSEOM guidelines for cervical cancer (epmc).pdf DeepDyve Pubget Overpricing